A double-blind, placebo-controlled, dose-finding, phase 2 study to assess the safety, tolerability, and immunogenicity of three dose levels of ACAM3000 modified vaccinia Ankara smallpox vaccine in adults with and without previous smallpox vaccination

Trial Profile

A double-blind, placebo-controlled, dose-finding, phase 2 study to assess the safety, tolerability, and immunogenicity of three dose levels of ACAM3000 modified vaccinia Ankara smallpox vaccine in adults with and without previous smallpox vaccination

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Jan 2014

At a glance

  • Drugs MVA 3000 (Primary)
  • Indications Smallpox
  • Focus Pharmacodynamics
  • Sponsors sanofi pasteur
  • Most Recent Events

    • 22 Jun 2007 Status change from in progress to completed.
    • 08 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top